English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis Journal article
Galling, Britta, Roldan, Alexandra, Hagi, Katsuhiko, Rietschel, Liz, Walyzada, Frozan, Zheng, Wei, Cao, Xiao-Lan, Xiang, Yu-Tao, Zink, Mathias, Kane, John M., Nielsen, Jimmi, Leucht, Stefan, Correll, Christoph U.. Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis[J]. WORLD PSYCHIATRY, 2017, 16(1), 77-89.
Authors:  ; et al.
Favorite | TC[WOS]:145 TC[Scopus]:173 | Submit date：2018/10/30
Antipsychotics  Polypharmacy  Augmentation  Monotherapy  Schizophrenia  Clozapine  Aripiprazole  
Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: Results from a systematic review and meta-analysis of randomized controlled trials Journal article
Galling,Britta, Roldán,Alexandra, Rietschel,Liz, Hagi,Katsuhiko, Walyzada,Frozan, Zheng,Wei, Cao,Xiao Lan, Xiang,Yu Tao, Kane,John M., Correll,Christoph U.. Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: Results from a systematic review and meta-analysis of randomized controlled trials[J]. Expert Opinion on Drug Safety, 2016, 15(5), 591-612.
Authors:  Galling,Britta;  Roldán,Alexandra;  Rietschel,Liz;  Hagi,Katsuhiko;  Walyzada,Frozan; et al.
Favorite | TC[WOS]:24 TC[Scopus]:28  IF:3.0/3.6 | Submit date：2021/03/02
Adverse Effects  Antipsychotics  Augmentation  Combination  Cotreatment  Metaanalysis  Monotherapy  Polypharmacy  Safety  Schizophrenia  Tolerability